Skip to main content

Animations

MJFF Publications

6771 - 6780 of 9033 Results
Title
Year
  • Year
  • 2021
  • 2025
  • 2024
  • 2020
  • 2024
  • 2024
  • 2020
  • 2024
  • 2022
  • 2024
  • Summary Details
    OPEN
    Title: Sex- and age‐dependent alterations of splenic immune cell profile and NK cell phenotypes and function in C57BL/6J mice
    Journal Name: Immunity & Ageing
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s12979-021-00214-3
    Citation Count: 99
  • Summary Details
    OPEN
    Title: Splicing accuracy varies across human introns, tissues, age and disease
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-024-55607-x
    Citation Count: 19
  • Summary Details
    OPEN
    Title: Developing Allosteric Chaperones for GBA1-Associated Disorders—An Integrated Computational and Experimental Approach
    Journal Name: International Journal of Molecular Sciences
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/ijms26010009
    Citation Count: 6
  • Summary Details
    OPEN
    Title: Development and Application of High-Throughput Single Cell Lipid Profiling: A Study of SNCA-A53T Human Dopamine Neurons
    Journal Name: iScience
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.isci.2020.101703
    Citation Count: 21
  • Summary Details
    OPEN
    Title: Structural basis for the pathogenicity of parkin catalytic domain mutants
    Journal Name: Journal of Biological Chemistry
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.jbc.2024.108051
    Citation Count: 7
  • Summary Details
    OPEN
    Title: Associations of cholinergic system integrity with cognitive decline in GBA1 and LRRK2 mutation carriers
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-024-00743-w
    Citation Count: 9
  • Summary Details
    OPEN
    Title: Human Dopaminergic Neurons Lacking PINK1 Exhibit Disrupted Dopamine Metabolism Related to Vitamin B6 Co-Factors
    Journal Name: iScience
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.isci.2020.101797
    Citation Count: 36
  • Summary Details
    OPEN
    Title: Alternative splicing expands the clinical spectrum of NDUFS6-related mitochondrial disorders
    Journal Name: Genetics in Medicine
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1016/j.gim.2024.101117
    Citation Count: 5
  • Summary Details
    OPEN
    Title: 17q21.31 sub-haplotypes underlying H1-associated risk for Parkinson’s disease are associated with LRRC37A/2 expression in astrocytes
    Journal Name: Molecular Neurodegeneration
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s13024-022-00551-x
    Citation Count: 59
  • Summary Details
    OPEN
    Title: Rapid iPSC inclusionopathy models shed light on formation, consequence, and molecular subtype of α-synuclein inclusions
    Journal Name: Neuron
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.neuron.2024.06.002
    Citation Count: 27
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.